Ultrasound Evaluation in Carpal Tunnel Syndrome
CTS-PD
Prospective Evaluation of Median Nerve Cross-Sectionall Area and Power Doppler Signal Changes in Patients With Carpal Tunnel Syndrome
1 other identifier
observational
100
0 countries
N/A
Brief Summary
This prospective cohort study aims to evaluate median nerve cross-sectional area and intraneural vascularity using power Doppler ultrasonography in patients with carpal tunnel syndrome. Ultrasonographic findings will be compared between diabetic and non-diabetic patients. Clinical severity and electrophysiological findings will be correlated with ultrasonographic parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2026
CompletedFirst Posted
Study publicly available on registry
February 25, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
April 9, 2026
February 1, 2026
7 months
February 19, 2026
April 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Intraneural Vascularity
Intraneural blood flow will be evaluated using power Doppler ultrasonography at the level of the carpal tunnel inlet. The presence and degree of intraneural vascularity will be graded using a semi-quantitative scoring system: 0 = No detectable intraneural flow 1. = Single vessel signal 2. = Multiple vessel signals 3. = Marked hypervascularity The total score ranges from 0 to 3. Higher scores indicate increased intraneural vascularity.
Baseline
Cross sectional Area
The cross-sectional area of the median nerve will be measured using ultrasonography at the level of the pisiform bone (carpal tunnel inlet) and proximal to transvers carpal ligament. Measurements will be obtained by tracing the inner border of the hyperechoic epineurium. Values will be recorded in square millimeters (mm²). Higher values indicate greater nerve swelling.
baseline
Secondary Outcomes (1)
Boston Carpal Tunnel Questionnaire
Baseline, 3th and 6th months
Interventions
The predictive power of cross-sectional area and intraneural blood flow measured by ultrasound on surgical outcomes will be tested.
Eligibility Criteria
Carpal Tunnel Syndrome Patients
You may qualify if:
- clinically and electrophysiologically confirmed carpal tunnel syndrome
- symptom duration \> 3 months
- written informed consent
You may not qualify if:
- previous wrist surgery
- cervical radiculopathy
- inflammatory arthritis
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Erickson M, Lawrence M, Lucado A. The role of diagnostic ultrasound in the examination of carpal tunnel syndrome: an update and systematic review. J Hand Ther. 2022 Apr-Jun;35(2):215-225. doi: 10.1016/j.jht.2021.04.014. Epub 2021 Apr 14.
PMID: 34261588BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 19, 2026
First Posted
February 25, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
April 9, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Data sharing is not planned due to patient confidentially and instutional policy